Daxor Announces That PCI Nuclear Pharmacy Acquires BVA-100 Blood Volume Analyzer

Daxor Announces That PCI Nuclear Pharmacy Acquires BVA-100 Blood Volume Analyzer

[at noodls] – Daxor Corporation (NYSE MKT: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from PCI Nuclear Pharmacy in Arizona. This agreement will … more

View todays social media effects on DXR

View the latest stocks trending across Twitter. Click to view dashboard

Share this post